Antengene Submits NDA for ATG-010 (Selinexor) in South Korea for rrMM and rrDLBCL ...Middle East

SHANGHAI and HONG KONG, Jan. 3, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology...

Hence then, the article about antengene submits nda for atg 010 selinexor in south korea for rrmm and rrdlbcl was published today ( Monday 04/01/2021 - 04:00 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Antengene Submits NDA for ATG-010 (Selinexor) in South Korea for rrMM and rrDLBCL )

Also on site :

• Yolo County fire prompts evacuations, closes southbound I-5 near Dunnigan
• Trump expects Nato allies to honour defence spending pledges, White House says
• What Comcast-NBCUniversal Split Faces On D.C.’s Trump-Influenced Regulatory Road